Catherine Novack
Stock Analyst at Jones Trading
(1.34)
# 3,419
Out of 4,876 analysts
20
Total ratings
17.65%
Success rate
-8.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $10.05 | +198.51% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $10.18 | +184.87% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.98 | +510.25% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.36 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $20.62 | +118.23% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.16 | +409.26% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $12.34 | +953.48% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.34 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $7.03 | +127.60% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.08 | +354.55% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.63 | +394.30% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.31 | +132.02% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.43 | +1,438.46% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.25 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.33 | +6,766.66% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $10.05
Upside: +198.51%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $10.18
Upside: +184.87%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.98
Upside: +510.25%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.36
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $20.62
Upside: +118.23%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.16
Upside: +409.26%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $12.34
Upside: +953.48%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.34
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.03
Upside: +127.60%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.08
Upside: +354.55%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.63
Upside: +394.30%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $4.31
Upside: +132.02%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.43
Upside: +1,438.46%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.25
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.33
Upside: +6,766.66%